Search
Showing results for "1"
Research
Adverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: A population-based cohort studyFemale survivors of AYA cancer have moderate excess risks of adverse obstetric and perinatal outcomes arising from subsequent pregnancies
Research
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodiesWe compared risk of newly detected infection and cervical abnormalities associated with HPV-16/18 between seronegative vs seropositive women (15-25 years) in...
Research
Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: A longitudinal population-based studyTo investigate the single and combined effectiveness of commonly prescribed secondary preventive medications (post-acute myocardial infarction (AMI)) in...
To coordinate and monitor clinical trial sites with the aim of meeting protocol and good clinical practice requirements.
The Wesfarmers Centre has established the Deborah Lehmann Research Award to acknowledge the significant contribution that Clinical Associate Professor Deborah Lehmann AO has made to paediatric infectious disease research.
Rett syndrome is a rare but serious neurological disorder that affects about 1 in 9,000 girls. Even more rarely, boys may be affected.
Research
Priority setting for children and young people with chronic conditions and disabilitiesThe aim of this project was to identify the top 10 priorities for childhood chronic conditions and disability (CCD) research from the perspectives of children and young people with lived experience, their parents and caregivers and the professionals who work with them.
News & Events
Exercise and hypo awareness studyOur researchers want to assess whether a home-based program of either low-intensity or intermittent high-intensity exercise can improve the ability to feel hypo symptoms in individuals (14-35 years) with impaired hypoglycaemia awareness.
Research
Updates in infant acute lymphoblastic leukemia and the potential for targeted therapyOutcomes for infants diagnosed under 1 year of age with KMT2A-rearranged acute lymphoblastic leukemia (ALL) have remained stagnant over the past 20 years. Successive treatment protocols have previously focused on intensification of conventional chemotherapy, but increased treatment-related toxicity and chemoresistance have led to a plateau in survival.